Santini, V., Sebert, M., Valcárcel, D., Borate, U., Yuan, W., Kapsalis, S. M., Simonot, L., Patel, P. A., Garcia-Manero, G. (2025). Phase 3 study of either ivosidenib monotherapy or azacitidine monotherapy in patients with IDH1-mutant myelodysplastic syndromes who are hypomethylating agent naive (PyramIDH).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps6584